Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TeamViewer is an international technology/software company headquartered in Göppingen, Germany. It develops and markets the widely used remote access/control software "TeamViewer," which enables users worldwide to connect with and manage computers or machines remotely. The company's offerings are not related to life sciences or healthcare R&D but are instead focused on digital transformation through IT connectivity platforms—including augmented reality and IoT solutions—for industries such as manufacturing, logistics, retail, education, banking/finance, and healthcare IT infrastructure. It went public on the Frankfurt Stock Exchange in September 2019 after previous ownership by GFI Software and then Permira.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TeamViewer.